Loading...
01/09 23:26
Loading...
Haleon PLC (HLN) is set to release its FY2024Q3 earnings performance on 10/31 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 2.85B and an earnings per share (EPS) of 0.11 for the FY2024Q3. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings forecast is neutral, reflecting potential revenue growth from Eroxon offset by challenges in the VMS sector and margin pressures.
6.3% from +
7.5%) highlights challenges in vitamins/minerals/supplements (VMS) in the U.S., offsetting some upside.
2. EPS: EPS revisions (-46% over 3 months) signal margin pressures. While Eroxon’s margins could be favorable, Morgan Stanley’s focus on "challenging comps" and potential cost inefficiencies in VMS likely weigh on profitability.
Rationale: Uncertainty around Eroxon’s launch timing and margin trajectory justifies a neutral stance, but asymmetric risks (downside EPS vs. upside revenue) favor hedging.
The earnings call summary presents a mixed picture: strong growth in Oral Health and market share gains in some areas are offset by challenges in the U.S. market and specific product lines like Advil and Centrum. The Q&A reveals management's cautious optimism, but also highlights issues like inventory pressures and competitive losses. Despite some positive elements, such as innovation and investment in key markets, the overall sentiment remains balanced due to unresolved challenges and uncertainties, leading to a neutral outlook for the stock price over the next two weeks.
The earnings call presents a mixed picture: positive revenue growth in key areas like Oral Health and a strong performance in India, but challenges in VMS and Centrum sales, along with foreign exchange headwinds. The lack of a share buyback or dividend program and unclear management responses contribute to uncertainty. The Q&A reveals cautious optimism for the second half, but no strong catalysts are present to suggest a significant stock price movement. Without a market cap, the stock's reaction is uncertain but likely neutral in the short term.
The earnings call reveals mixed signals: strong organic growth in key areas like Oral Health, but overall revenue is affected by foreign exchange headwinds and disposals. The company maintains stable margins and financial health, but lacks a share buyback program. The Q&A section highlights management's confidence in future growth through innovation and investment, but also notes consumer softness and tariff challenges. The absence of a new partnership or significant shareholder returns tempers positive sentiment. Without a market cap, the stock's reaction is uncertain, thus a 'Neutral' rating is appropriate.
Haleon PLC (HLN) is scheduled to release its FY2024Q3 earnings report onOct 31, 2024, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 2.85B in revenue and an EPS of 0.11 for Haleon PLC's FY2024Q3.
Intellectia's exclusive AI algorithms forecast a Neutral forHaleon PLC's FY2024Q3 earnings, with a prediction date of Oct 31, 2024. Haleon PLC The earnings forecast is neutral, reflecting potential revenue growth from Eroxon offset by challenges in the VMS sector and margin pressures.
Leverage Intellectia's AI forecast to position trades ahead of theOct 31, 2024 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
